References
- Avizienyte E, Loukola A, Roth S, et al (1999). LKB1 somatic mutations in sporadic tumors. Am J Pathol, 154, 677-81. https://doi.org/10.1016/S0002-9440(10)65314-X
- Cha HJ, Kim J, Hong SM, et al(2012). Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma. Ann Surg Oncol, 19, 404-11. https://doi.org/10.1245/s10434-011-1856-3
- Chen HP, Shieh JJ, Chang CC, et al (2013). Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut, 62, 606-15. https://doi.org/10.1136/gutjnl-2011-301708
- Esteller M, Avizienyte E, Corn PG, et al (2000). Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene, 19, 164-8. https://doi.org/10.1038/sj.onc.1203227
- Fenton H, Carlile B, Montgomery EA, et al (2006). LKB1 protein expression in human breast cancer. Appl Immunohistochem Mol Morphol, 14, 146-53. https://doi.org/10.1097/01.pai.0000176157.07908.20
- Fernandez P, Carretero J, Medina PP, et al (2004). Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Oncogene, 23, 5084-91. https://doi.org/10.1038/sj.onc.1207665
- Gao Y, Ge G, Ji H(2011). LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor. Protein Cell, 2, 99-107. https://doi.org/10.1007/s13238-011-1021-6
- Herrmann JL, Byekova Y, Athar M (2011). Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers. Cancer Lett, 306, 1-9. https://doi.org/10.1016/j.canlet.2011.01.014
- Hezel AF, Gurumurthy S, Granot Z, et al (2008). Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol, 28, 2414-25. https://doi.org/10.1128/MCB.01621-07
- Kim DW, Chung HK, Park KC, et al (2007). Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC). Mol Endocrinol, 21, 3039-49. https://doi.org/10.1210/me.2007-0269
- Li PD, Zhang WJ, Zhang MY, et al (2012). Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients. Med Oncol, 29, 3070-6. https://doi.org/10.1007/s12032-012-0268-y
- Miyoshi H, Deguchi A, Nakau M, et al (2009). Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice. Cancer Sci, 100, 2046-53. https://doi.org/10.1111/j.1349-7006.2009.01284.x
- Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D (2012). Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res, 14, R35. https://doi.org/10.1186/bcr3128
- Nakau M, Miyoshi H, Seldin MF, et al (2002). Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res, 62, 4549-53.
- Sahin F, Maitra A, Argani P, et al (2003). Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod Pathol, 16, 686-91. https://doi.org/10.1097/01.MP.0000075645.97329.86
- Shackelford DB, Shaw RJ (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer, 9, 563-75. https://doi.org/10.1038/nrc2676
- Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM (2002). The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res, 8, 2085-90.
- Su GH, Hruban RH, Bansal RK, et al (1999). Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol, 154, 1835-40. https://doi.org/10.1016/S0002-9440(10)65440-5
- Takeuchi Y, Ikeda F, Moritou Y, et al (2012). The impact of patatinlike phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol.
-
Yang H, Zhai G, Ji X, et al (2012). LAPTM4B allele
$^*2$ is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma. PLOS ONE, 7, e34984. https://doi.org/10.1371/journal.pone.0034984 - Zha TZ, Hu BS, Yu HF, et al (2012). Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumour Biol, 33, 2125-34. https://doi.org/10.1007/s13277-012-0472-6
- Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM (2006). Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res, 4, 843-9. https://doi.org/10.1158/1541-7786.MCR-06-0118
Cited by
- Drug Resistance Effects of Ribosomal Protein L24 Overexpression in Hepatocellular Carcinoma HepG2 Cells vol.15, pp.22, 2014, https://doi.org/10.7314/APJCP.2014.15.22.9853
- LKB1 Loss at Transcriptional Level Promotes Tumor Malignancy and Poor Patient Outcomes in Colorectal Cancer vol.21, pp.S4, 2014, https://doi.org/10.1245/s10434-014-3824-1
- LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment vol.125, pp.11, 2015, https://doi.org/10.1172/JCI82152
- Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs vol.34, pp.3, 2015, https://doi.org/10.3892/or.2015.4092
- Rewiring cell polarity signaling in cancer vol.34, pp.8, 2015, https://doi.org/10.1038/onc.2014.59
- The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis vol.11, pp.4, 2016, https://doi.org/10.1371/journal.pone.0152674
- Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma vol.13, pp.3, 2017, https://doi.org/10.3892/ol.2017.5631
- Sodium butyrate induces autophagy in colorectal cancer cells through LKB1/AMPK signaling pp.1877-8755, 2018, https://doi.org/10.1007/s13105-018-0651-z
- Liver kinase B1 suppresses growth of lung cancer cells through sonic hedgehog signaling pathway vol.42, pp.8, 2018, https://doi.org/10.1002/cbin.10965